Oncology

Nearly half of patients with metastatic melanoma treated with a combination of the immune checkpoint inhibitors nivolumab and ipilimumab have survived cancer-free, underscoring the impact of immunotherapy in advanced melanoma.

Duloxetine, a widely used and popular antidepressant, has been recalled by U.S. Food and Drug Administration (FDA) due to the detection of N-nitroso-duloxetine, a chemical suspected of being carcinogenic.

Diet quality could play a role in the progression of prostate cancer for men undergoing active surveillance.

The U.S. FDA has approved a wearable device for treating metastatic non-small cell lung cancer in adults. Used with PD-1/PD-L1 inhibitors or docetaxel, it showed a median survival of 13.2 months.

A new study from The University of Texas MD Anderson Cancer Center has revealed that a combination of dual immunotherapy and chemotherapy improves outcomes for patients with metastatic NSCLC who harbor specific mutations.

Breast cancer deaths have declined by 44% since 1989, but rising diagnoses and racial disparities highlight the need for targeted care and early detection.

Greater BRCA genetic testing among men has been highlighted as a critical need in a recently published review

One-third of popular social media articles about breast, colorectal, lung, and prostate cancer contained misleading or harmful information, according to a new study.